News
EQS-News: Hannover Re increases premium volume in the renewals and achieves Group profit of EUR 2.3 billion for 2024
Merck (MRK) Q4 2024 Earnings Call Transcript
Image source: The Motley Fool.
Merck (NYSE: MRK)Q4 2024 Earnings CallFeb 04, 2025, 9:00 a.m. ET
Operator
Source Fool.com
Why Merck Stock Is Plummeting Today
Shares of Merck (NYSE: MRK) were trading lower on Tuesday. The company's stock had lost 10.1% as of 2 p.m. ET, but was down as much as 12.5% earlier in the day. The drop comes as the S&P 500 gained
EQS-News: Infineon has a slightly better start to the fiscal year than expected and raises its outlook for the year due to currency effects
2 Dark Horse Catalysts for Rivian Stock in 2025
Investors merely glancing at Rivian (NASDAQ: RIVN) stock might avoid the company in 2025 simply because it doesn't appear to have many catalysts. The next vehicle launch won't be until early 2026
EQS-News: Symrise achieves significant sales growth in 2024 with a strong increase in profitability
Why This Beaten-Down Stock Is a Buy in 2025 and Beyond
Last year wasn't a good one for Merck (NYSE: MRK), one of the largest pharmaceutical companies in the world. The healthcare giant is dealing with the fast-approaching patent cliff for its most
EQS-News: Vonovia shareholders back domination and profit and loss transfer agreement with Deutsche Wohnen
EQS-Adhoc: BASF SE: BASF Group releases preliminary figures for full year 2024
EQS-News: PUMA accelerates growth throughout 2024 and initiates program to increase profitability
EQS-Adhoc: PUMA SE: PUMA announces preliminary results for the fourth quarter and the full year 2024
EQS-Adhoc: adidas finishes successful year with better-than-expected fourth quarter results
EQS-News: Zalando launches public tender offer for ABOUT YOU
PUMA Recognized as Top Employer in 50 Countries
Sports company PUMA is the only company to be recognized as a Top Employer in 50 different countries and globally by Top Employers Institute in 2025.
This press release features multimedia. View
PUMA in 50 Ländern als Top-Employer ausgezeichnet
Das Sportunternehmen PUMA ist das einzige Unternehmen weltweit, das vom Top Employers Institute in 50 Ländern und als Gesamtkonzern die Top-Employer Zertifizierung 2025 erhalten hat.
Diese
EQS-Adhoc: Zalando SE: Zalando SE exceeds its own profitability guidance for the financial year 2024 after a better than expected fourth quarter
EQS-News: Deutsche Wohnen to sell nursing company PFLEGEN & WOHNEN to Hamburg Municipal Holding Company HGV
Rivian's Deliveries Rebound. Is the Stock a Buy in 2025?
The bulls and bears have been in a good old-fashioned wrestling match with Rivian Automotive (NASDAQ: RIVN) stock over the past year, each landing some punches. For every big win, such as Rivian's
Self-Driving Truck Stock Aurora Innovation Is Surging on a New Deal With Nvidia
Shares of autonomous trucking start-up Aurora Innovation (NASDAQ: AUR) were trading sharply higher on Tuesday morning, after the company announced a major deal with Nvidia and Continental to build
2 High-Yield Dividend Stocks to Buy Early in 2025
The healthcare sector has long been a sanctuary for income investors seeking stability and growth. Within this realm, Bristol-Myers Squibb (NYSE: BMY) and Merck & Co. (NYSE: MRK) stand out for their
Should You Buy Rivian Stock While It's Below $15?
Rivian Automotive (NASDAQ: RIVN) stock has been on the upswing in the latter part of the year. Shares of the electric vehicle (EV) maker have soared 38% over the past month, as of this writing. Yet
2 Reasons to Sell Merck Stock and 1 Reason to Buy
There is plenty to like about Merck (NYSE: MRK). It is one of the largest pharmaceutical companies and the owner of the world's current best-selling drug, cancer medicine Keytruda. Merck generates
A Deeper Dive Into 2 Huge Rivian Victories
While 2025 could shape up into a rather quiet year for Rivian Automotive (NASDAQ: RIVN), with a lack of major launches or catalysts, the end of 2024 has been anything but muted. Investors have to
Is Merck the Next Big Weight-Loss Stock?
Watch out, Eli Lilly and Novo Nordisk. Merck (NYSE: MRK) is hungrily looking to take a bite out of the weight-loss drugs market.
Amidst an evolving field of competitors, the big pharma is committing
Is Lucid Taking a Page out of Rivian's Playbook?
The automotive industry can be a bit of a copycat industry. When one automaker finds success with a certain strategy, you can bet the competitors across the street take notice. We might be seeing